NEW YORK GENOME CENTER, INC.: Single Audit Reports and Findings

NEW YORK GENOME CENTER, INC.'s most recent single audit in the Federal Audit Clearinghouse covers fiscal year 2025, accepted September 30, 2026; the auditor observed on that filing is KPMG LLP. It reported no findings. 10 filings from 2016 to 2025 are on record. Data as of 2026-11-06.

Data as of Nov 6, 2026 · Source: Federal Audit Clearinghouse (public data)

Single audits by year

One row per audit year as the Federal Audit Clearinghouse accepted it. The auditor named is the one observed on that filing; NEW YORK GENOME CENTER, INC. is recorded in NEW YORK, New York under EIN 800631734, and the Clearinghouse records it as a nonprofit. Each report opens on the Clearinghouse itself; how to search the Federal Audit Clearinghouse explains the rest of the reporting package.

Single audits filed by NEW YORK GENOME CENTER, INC.
Audit yearFiscal year endFederal expendedThreshold appliedAuditor observedOpinionFindingsMW / SDFAC report
20252025-12-31$20,419,101$1,000,000KPMG LLPUnmodified0—2025-12-GSAFAC-0000431698
20242024-12-31$21,849,375$750,000KPMG LLPUnmodified0—2024-12-GSAFAC-0000383103
20232023-12-31$22,587,622$750,000KPMG LLPUnmodified0—2023-12-GSAFAC-0000056543
20222022-12-31$14,466,116$750,000KPMG LLPUnmodified0—2022-12-CENSUS-0000245306
20212021-12-31$15,488,259$750,000KPMG LLPUnmodified0—2021-12-CENSUS-0000245306
20202020-12-31$13,438,130$750,000KPMG LLPUnmodified0—2020-12-CENSUS-0000245306
20192019-12-31$19,339,452$750,000KPMG LLPUnmodified0—2019-12-CENSUS-0000245306
20182018-12-31$17,318,302$750,000KPMG LLPUnmodified0—2018-12-CENSUS-0000245306
20172017-12-31$14,350,810$750,000KPMG LLPUnmodified0—2017-12-CENSUS-0000245306
20162016-12-31$18,076,858$750,000KPMG LLPUnmodified0—2016-12-CENSUS-0000245306

When is the next single audit due?

If NEW YORK GENOME CENTER, INC. is again required to have a single audit for the fiscal year ending Dec 31, 2026, the reporting package is due to the Federal Audit Clearinghouse by Sep 30, 2027 at the latest.

Whether an audit is required depends on federal awards expended in that year (the single audit threshold). The rule, 2 CFR 200.512(a): the reporting package is due within 30 calendar days after the auditee receives the auditor's report or nine months after the end of the audit period, whichever is earlier; the date above is the nine-month date, moved to Monday when it falls on a weekend. Last verified: 2026-11-15.

Which federal programs did this organization report?

From the most recent accepted report, as listed on its schedule of expenditures of federal awards (SEFA). "Major" is the designation the auditor made under 2 CFR 200.518, not ours.

Federal programs on the most recent report
ALNProgramExpendedMajor
93.RDContract$2,994,451Yes
93.310TRANS-NIH RESEARCH SUPPORT$1,348,998Yes
93.172HUMAN GENOME RESEARCH$1,255,517Yes
93.310TRANS-NIH RESEARCH SUPPORT$1,210,549Yes
93.242MENTAL HEALTH RESEARCH GRANTS$1,000,132Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$832,365Yes
93.395CANCER TREATMENT RESEARCH$818,406Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$800,182Yes
93.172HUMAN GENOME RESEARCH$756,578Yes
93.172HUMAN GENOME RESEARCH$731,429Yes
93.172HUMAN GENOME RESEARCH$659,164Yes
93.859BIOMEDICAL RESEARCH AND RESEARCH TRAINING$622,081Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$618,980Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$526,071Yes
93.310TRANS-NIH RESEARCH SUPPORT$477,445Yes
93.396CANCER BIOLOGY RESEARCH$431,223Yes
93.310TRANS-NIH RESEARCH SUPPORT$392,673Yes
93.859BIOMEDICAL RESEARCH AND RESEARCH TRAINING$351,300Yes
93.242MENTAL HEALTH RESEARCH GRANTS$345,335Yes
93.172HUMAN GENOME RESEARCH$316,513Yes
93.855ALLERGY AND INFECTIOUS DISEASES RESEARCH$315,654Yes
93.242MENTAL HEALTH RESEARCH GRANTS$298,795Yes
93.866AGING RESEARCH$235,918Yes
93.394CANCER DETECTION AND DIAGNOSIS RESEARCH$228,089Yes
93.393CANCER CAUSE AND PREVENTION RESEARCH$228,037Yes

What findings did the auditor report?

The reference is the auditor’s; the requirement is the Compliance Supplement category the auditor selected. The finding text itself is not reproduced here; the FAC report linked above carries it in full. What the two severity levels mean: material weakness vs significant deficiency.

The most recent report lists no finding.

Form 990 and IRS registration

Form 990 "accounting fees" (Part IX line 11c) cover all accounting services reported by the organization and are not the price of an audit engagement.

Where to find the return itself, and what our Form 990 data covers: Form 990 lookup.

Most recent return
990 for 2024-12
Total revenue
$82,342,631
Total assets
$166,954,755
Accounting fees (Part IX line 11c)
$141,144
Paid preparer
KPMG LLP
IRS object id
202533099349302893
NTEE code
E22
Exempt under
501(c)(3)
Ruling year
2012
BMF release
2026-10-20

Read next

How we computed this

Every row comes from the Federal Audit Clearinghouse record named beside it, one report per audit year, with a resubmission superseding the filing it replaces. The auditor is the one named on that filing — it is not a statement about who audits NEW YORK GENOME CENTER, INC. now. Form 990 figures come from the IRS e-filed return named by its object id. This page exists because the organization filed at least two single audits, or one with a finding.

Cite this page

AuditRadar. “New York Genome Center, Inc. Single Audit FY2025.” https://getauditradar.com/single-audits/ny/new-york-genome-center-inc-800631734/. Data as of 2026-11-06.